Evidence map›Paper›PMID 24898584›Full record

ArticleAmerican journal of physiology. Cell physiology2014

Cystic fibrosis transmembrane conductance regulator dysfunction in VIP knockout mice.

Nicole G Alcolado, Dustin J Conrad, Diogo Poroca, Mansong Li, Walaa Alshafie, Frederic G Chappe, Ryan M Pelis, Younes Anini, Zhaolin Xu, Sayyed Hamidi and 2 more

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Acquired dysfunction of CFTR underlies cystic fibrosis-like disease of the canine gallbladder.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicole G AlcoladoDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;
Dustin J ConradDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;
Diogo PorocaDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;
Mansong LiDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;
Walaa AlshafieDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;
Frederic G ChappeDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada;
Ryan M PelisDepartment of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada;
Younes AniniDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Obstetrics and Gynecology, Dalhousie University, Halifax, Nova Scotia, Canada; and.
Zhaolin XuDepartment of Pathology, Dalhousie University and QE II Health Sciences Centre, Halifax, Nova Scotia, Canada;
Sayyed HamidiDepartment of Medicine and Pulmonary Critical Care, Stony Brook University, Stony Brook, New York.
Sami I SaidDepartment of Medicine and Pulmonary Critical Care, Stony Brook University, Stony Brook, New York.
Valerie M ChappeDepartment of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada; valerie.chappe@dal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasoactive intestinal peptide (VIP), a neuropeptide, controls multiple functions in exocrine tissues, including inflammation, and relaxation of airway and vascular smooth muscles, and regulates CFTR-dependent secretion, which contributes to mucus hydration and local innate defense of the lung. We had previously reported that VIP stimulates the VPAC1 receptor, PKCϵ signaling cascade, and increases CFTR stability and function at the apical membrane of airway epithelial cells by reducing its internalization rate. Moreover, prolonged VIP stimulation corrects the molecular defects associated with F508del, the most common CFTR mutation responsible for the genetic disease cystic fibrosis. In the present study, we have examined the impact of the absence of VIP on CFTR maturation, cellular localization, and function in vivo using VIP knockout mice. We have conducted pathological assessments and detected signs of lung and intestinal disease. Immunodetection methods have shown that the absence of VIP results in CFTR intracellular retention despite normal expression and maturation levels. A subsequent loss of CFTR-dependent chloride current was measured in functional assays with Ussing chamber analysis of the small intestine ex vivo, creating a cystic fibrosis-like condition. Interestingly, intraperitoneal administration of VIP corrected tissue abnormalities, close to the wild-type phenotype, as well as associated defects in the vital CFTR protein. The results show in vivo a primary role for VIP chronic exposure in CFTR membrane stability and function and confirm in vitro data.

Indexed as

AnimalsCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsGene Expression RegulationIntestine, SmallLungMiceMice, KnockoutRespiratory MucosaTracheaVasoactive Intestinal PeptideCystic Fibrosis Transmembrane Conductance RegulatorVasoactive Intestinal PeptideCFTRcystic fibrosisepitheliumVIPVIP-knockout mice

Identifiers

PMID24898584
PMCPMC4101624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.